| Literature DB >> 36185245 |
Igor Romanishkin1, Tatiana Savelieva1,2, Alexandra Kosyrkova3, Vladimir Okhlopkov3, Svetlana Shugai3, Arseniy Orlov2, Alexander Kravchuk3, Sergey Goryaynov3, Denis Golbin3, Galina Pavlova3,4, Igor Pronin3, Victor Loschenov1,2.
Abstract
The neurosurgery of intracranial tumors is often complicated by the difficulty of distinguishing tumor center, infiltration area, and normal tissue. The current standard for intraoperative navigation is fluorescent diagnostics with a fluorescent agent. This approach can be further enhanced by measuring the Raman spectrum of the tissue, which would provide additional information on its composition even in the absence of fluorescence. However, for the Raman spectra to be immediately helpful for a neurosurgeon, they must be additionally processed. In this work, we analyzed the Raman spectra of human brain glioblastoma multiforme tissue samples obtained during the surgery and investigated several approaches to dimensionality reduction and data classificatin to distinguish different types of tissues. In our study two approaches to Raman spectra dimensionality reduction were approbated and as a result we formulated new technique combining both of them: feature filtering based on the selection of those shifts which correspond to the biochemical components providing the statistically significant differences between groups of examined tissues (center of glioblastoma multiforme, tissues from infiltration area and normally appeared white matter) and principal component analysis. We applied the support vector machine to classify tissues after dimensionality reduction of registered Raman spectra. The accuracy of the classification of malignant tissues (tumor edge and center) and normal ones using the principal component analysis alone was 83% with sensitivity of 96% and specificity of 44%. With a combined technique of dimensionality reduction we obtained 83% accuracy with 77% sensitivity and 92% specificity of tumor tissues classification.Entities:
Keywords: biochemical components; dimensionality reduction; glioblastoma multiforme; optical biopsy; principal component analysis; raman spectroscopy
Year: 2022 PMID: 36185245 PMCID: PMC9520479 DOI: 10.3389/fonc.2022.944210
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 5.738
Figure 1Raman spectra measurement setup.
Figure 2Normalized mean Raman signal from normal brain tissue (blue), tumor edge (magenta) and tumor center (orange) with standard error of the mean indicated by a translucent color.
Figure 3Mean Raman signal in amide bands (blue – normal tissue, magenta - tumor edge, orange - tumor center). Numbers in horizontal labels denote the range of Raman shifts. *p<0.05, **p<0.001.
Figure 6Mean Raman signal in bands of water and hemoglobin (blue – normal tissue, magenta - tumor edge, orange - tumor center). Numbers in horizontal labels denote the range of Raman shifts. *p<0.05.
Figure 4Mean Raman signal in bands of cholesterol, phospholipids and protein (blue – normal tissue, magenta - tumor edge, orange - tumor center). Numbers in horizontal labels denote the range of Raman shifts. *p<0.05.
Figure 5Mean Raman signal in bands of carotenoids (blue – normal tissue, magenta - tumor edge, orange - tumor center). Numbers in horizontal labels denote the range of Raman shifts. *p<0.05.
Figure 7PCA of all points in the range of 900–1800 cm-1 (blue – normal tissue, magenta - tumor edge, orange - tumor center). The background color signifies the classification by SVM.
Figure 8PCA of pre-filtered data (blue – normal tissue, magenta - tumor edge, orange - tumor center). The background color signifies the classification by SVM.